key: cord-0691524-r7splnn7 authors: Fu, Wei; Chen, Chi; Chen, Xin‐Lin; Wang, Kun; Zuo, Peiyuan; Liu, Yuwei; Zhang, Meng; Zhao, Xiaofang; Xie, Songpu; Zhang, Hao; Geng, Yan; Liu, Chengyun title: A U‐shaped association between baseline neutrophil count and COVID‐19‐related mortality: a retrospective cohort study date: 2021-01-19 journal: J Med Virol DOI: 10.1002/jmv.26794 sha: 3e3dc658a94aee7c00163920dfd882865e5baf30 doc_id: 691524 cord_uid: r7splnn7 BACKGROUND: Several descriptive studies have reported that higher neutrophil count (NC) may be correlated with poor prognosis in patients with confirmed COVID‐19 infection. However, the findings from these studies are limited by methodology and data analysis. METHODS: This study is a cohort study. We non‐selectively and consecutively collected a total of 663 participants in a Chinese hospital from January 7 to February 28. Standardized and two‐piecewise Cox regression model were employed to evaluated the association between baseline neutrophil count (bNC), NC change rate (NCR), and death. RESULTS: bNC had a U‐shaped association with death. In the range of 0.1 to ≤1.49×10(9) /L (HR = 0.19, 95% CI = 0.05 to 0.66) and > 3.55×10(9) /L of bNC (HR = 2.82, 95% CI = 1.19 to 6.67), the trends on bNC with mortality were opposite. By recursive algorithm, the bNC at which the risk of the death was lower was range of >1.49 to ≤3.55×10(9) /L (HR=13.64, 95%CI=0.25 to 74.71). In addition, we find NCRs (NCR1 and NCR2) is not associated with COVID‐19‐related deaths. CONCLUSIONS: Compared with NCR, bNC has the potential to be used for early risk stratification in patients with COVID‐19 infection. The relationship between bNC and mortality was U‐shaped. The safe range of bNC was 1.64 to 4.0 ×10(9) /L. Identifying the correlation may be helpful for early risk stratification and medical decision making. This article is protected by copyright. All rights reserved. We non-selectively collected consecutive cases from the First People's Hospital of Jiangxia District Wuhan City, China. To mitigate the potential concern on privacy, the identity information of participants was encoded as the non-traceable codes in this study. Data collection of participants was performed using hospital electronic medical record system. The local ethics committee of the First People's Hospital of JiangXia District approved this study. Informed consent of involving participants was not required because of the retrospective design of the study and the analysis used anonymous data. Initially, 1066 participants were initially participated in this study; 443 participants were subsequently excluded from this study, leaving 623 cases for the final data analysis (see figure1 for details). The start time and end time of the clinical data of collection for these involving participants was January 7 and February 28, respectively. All patients were followed up until discharge. Inclusion criteria included adults (> 14 years) suffered from COVID-19 infection. The diagnostic criteria are based primarily on Diagnosis and treatment of novel coronavirus pneumonia (seventh edition) [4] . In the guide, the diagnostic criteria of COVID-19 were based on the virus RNA detection, the clinical characteristics, chest imaging, and the ruling out common pathogen. Exclusion criteria included: (1) . Those patients who still hospitalized before February 29; (2)Those patients with missing neutrophil data; (3) those who died during admission; (4) those who had previous gastrointestinal surgery; (5) those who were diagnosed as severe type of COVID-19 after admission; (6) those patients with tumor duration. The body temperature returned to normal for more than 3 days, the respiratory symptoms significantly improved, the pulmonary imaging showed that the inflammation was obviously absorbed, and the respiratory pathogenic nucleic acid test was negative for two consecutive times (sampling interval was at least 1 day). NCs measured at various time points were recorded as continuous variable. During the entire disease course, the different trend of NC between survivors and non-survivors were observed (Supplemental figure 1) . Therefore, we used bNC, NC change rates as the target exposure variable. The NC change rate formula is as follows: NC change rate1(NCR1)=Absolute (NC second -NC baseline )/NC baseline ; NC change rage 2(NCR2)=Absolute(NC third -NC baseline )/NC baseline . Because bNC, NCR1 and NCR2 is skewed, we therefore converted them to log2 function. The detailed process of measure of NC is described as follows: 2ml of blood was drawn from the vein, and then put into an EDTA-anticoagulation tube, and sent to the central laboratory of the hospital for analysis by the BC-3000 auto haematology analyser (Mindray Medical International, Inc.). Our interesting outcome variable was COVID-19-related death (dichotomous variable: 1= survival, 0= Non-survival). The covariates involving in this study was selected based on our clinical experience and studies of others examining risk factors for COVID-19-related death [1] [2] [3] [5] [6] [7] [8] [9] [10] [11] [12] . Therefore, the following variables were used as covariates: (1) continuous variables: age (year), baseline lymphocyte count (×10 9 /L), baseline platelet count ( ×10 9 /L). (2) categorical variables: sex(male/female), hypertension (yes/no), diabetes(yes/no) and CAD history (yes/no), respiratory failure (yes/no), cardiac insufficiency (yes/no), cough (yes/no) and fever (yes/no). This article is protected by copyright. All rights reserved. Given that there are currently no standardized treatment guidelines for COVID-19 pneumonia, clinical treatment is based on symptomatic and supportive treatment, including the use of glucocorticoids, antiviral drugs, oxygen inhalation, traditional Chinese medicine, and exacerbations mechanical ventilation therapy. Baseline characteristics of participants are expressed as mean ± standard deviation(SD)(Gaussian distribution) or median (range) (Skewed distribution) for continuous variables, and as percentages for categorical variables. χ2 (categorical variables), One-Way ANOVA test (normal distribution), or Kruskal-Whallis H test (skewed distribution) were used to detect the differences among different bNC. Our data analysis is based on the purpose of early risk stratification. Therefore, we used the baseline, the first two and the first three neutrophil change rates as exposure variables. Univariate and multivariate Cox proportional-hazards regression model were employed to test the correlation between exposure variables and COVID-19-related death with three distinct models. Model 1 is the non-adjusted model with no covariates adjusted. Model 2 is the minimally-adjusted model with only sociodemographic variables adjusted. Model 3 is the fully-adjusted model with covariates presented in Table 1 adjusted). Because Cox proportional-hazards regression model based methods are often suspected for their inability to deal with non-linear models, on that account, nonlinearity between neutrophil count and COVID-19-related decease were addressed using cox proportional hazards regression model with cubic spline functions and the smooth curve fitting (penalized spline method). If nonlinearity was detected, we firstly calculated the inflection point using recursive algorithm, and then constructed a two-piecewise Cox proportional-hazards regression model on both sides of the inflection point. To ensure the robustness of our results, we performed a sensitivity analysis. We converted log 2 bNC into a categorical variable according to the quartile, and calculated the P for trend. matched by a 114% increases in non-survivor (2.14, 1.12 to 4.08). To verify the robustness of our findings, a sensitivity analysis was performed. We convert log2-neutrophil from a continuous variable to a categorical variable (according to quartile). The results show that the trend of the hazards ratio in different groups of log2-bNC is inequidistant. The results obtained from the sensitivity analysis indicated that clarification of nonlinearity between log2-bNC on COVID-19-related death is necessary. For log 2 NCR1 and log 2 NCR2, no significant correlations were detected in unadjusted, minimally-adjusted and fully-adjusted models. These findings demonstrated that in our data, there is no evidence that NCR1and NCR2 are associated with COVID-19-related death. By the Cox proportional-hazards regression model with cubic spline functions and smooth curve fitting, we observed that the correlation between log 2 -bNC and death is nonlinear ( figure 2) . Wherefore, data were fit to a two-piecewise cox proportional-hazards regression model (table 3) . By recursive algorithm, we first obtained the inflection point was 0.58 and 1.83 of log2-bNC (1.49 and 3.55 ×10 9 /L of bNC, by inverse log2 logarithmic conversion). At the range of 0.1 to ≤1.49×10 9 /L of bNC (by inverse log2 logarithmic conversion), the HR and 95%CI was 0.19, 0.05 to 0.66, respectively. At the range of >1.49 to ≤3.55×10 9 /L of bNC, the HR and 95%CI was 13.64, 0.25 to 74.71, respectively. At the range of > 3.55×10 9 /L of bNC, the HR and 95%CI was 2.82, 1.19 to 6.67, respectively. In view of the previously reported descriptive studies have mentioned the potential association between neutrophil elevation and poor prognosis, we therefore would like to clarify (1) the trend of neutrophils count throughout the course of the disease (2) Compared with short-term change rate of NC, bNC has more potential as a predictor for future prediction model development. In addition, the biggest gain of this study is the discovery of a U-shaped relationship between bNC and death. Within the range of 1.6-4.0×10 9 /L, patients have a relatively low risk of death. This helps physicians to early assess the risk of poor prognosis in patients with COVID-19 infection. Three previously published articles have addressed the association between bNC and clinical characteristics of COVID-19 infection (study size: 59 to 452). Based on patients with COVID-19, Qin C et al [13] reported that severe cases tend to have lower lymphocytes counts, higher leukocytes counts. Besides, Mo P et al [14] investigated 155 consecutive patients with confirmed COVID-19 in Zhongnan Hospital of Wuhan University as the study population and obtained similar results. Li H et al [15] suggested that here was an increase in the proportion of neutrophils count in pregnant women (n = 41) and children (n = 4) and non-pregnant women (n = 14) infected with COVID-19. It is different from our findings. We attribute this difference to (1) the setting of the outcome variables. The outcome variable for this study was death; the outcome variable set by the above-mentioned researchers was the type of disease (servere, non-severe); (2) Most of the previous studies were cross-sectional designs. Therefore, the choice of algorithm was logistic regression. However, this study was a cohort study. Therefore, considering the influence of time, we used cox regression. In our data, cox regression is more sensitive than logistic regression. (3) None of the previous studies have discussed non-linear relationships, so the nonlinearity can not be found. Although there is not much evidence, previous studies still tend to attribute the deterioration and death of patients with COVID-19 infection to "cytokine storm" and immunologic abnormality, and these mechanisms also exist in respiratory syndrome (SARS), Middle East respiratory syndrome coronavirus (MERS-CoV) and influenza A (H1N1) [16] [17] [18] [19] . A remarkable finding in our Accepted Article study was that both the increasing and depressed bNC was associated with fatal outcome of COVID-19 patients. Neutrophil chemotaxis and transport play an important role in the host's immune defense process, but excessive infiltration of neutrophils can cause harmful inflammation. This excessive infiltration may have a profound interaction with the cytokine storm during virus invasion [20] [21] [22] . Therefore, an increase in bNC associated with an increased risk of death can be explained. The mechanism of COVID-19 infection leading to neutropenia has not yet been elucidated. However, excessive reduction of neutrophils often leads to subsequent immunodeficiency (similar to bone marrow suppression after chemotherapy), and increase the risk of co-infected with bacteria due to low immune function. Some challenges may be raised. Firstly, all patient data is collected after admission. It means that pre-hospital interventions (administration of antibiotics) can interfere with the accuracy of neutrophil counts. However, the effect of antibiotics on neutrophils is to reduce their concentration in peripheral blood, and our finding shows that the relationship between high neutrophils and COVID-19-associated death is positively correlated, that is, high neutrophils can increase the risk of death. Therefore, the effect of antibiotics on neutrophils is opposite to our results, but will make our results more strong. Secondly, giving patients antipyretics before admission can cause misclassification of fever. However, the results of the multiple cox regression model indicated that fever can increase the risk of death in patients with COVID-19 infection. Therefore, the bia direction of antipyretic was biased towards the reduction of mortality, which would lead to the result biased towards null. In addition, for patients with COVID-19 infection, there is no evidence on the effect of antipyretics on neutrophil counts. Thus, even if patients were misclassified as having fever due to oral antipyretics, the impact of this misclassification on the association of bNC with COVID-19-related mortaliy is unknown. Lastly, changes in the patient's condition will cause neutrophils to change over time, and this time-dependent variability will affect the results. However, by analyzing the time-dependent trend of neutrophils in three time points, the results showed that there was no statistical difference between the neutrophils of the third time and those of the second time (Supplemental Figure 2) . Therefore, our setting of the neutrophil change rate does not need to consider the effect of the significant difference between the second and third neutrophils on the change rate. A Novel Coronavirus from Patients with Pneumonia in China What we know so far: COVID-19 current clinical knowledge and research Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review General Office of the National Health Commission of the People's Republic of China, Office of the State Administration of Traditional Chinese Medicine. Diagnostic and therapeutic protocol for novel coronavirus pneumonia Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19 Clinical characteristics of refractory COVID-19 pneumonia in Wuhan Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin Epidemiological investigation on a cluster epidemic of COVID-19 in a collective workplace in Tianjin Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical Characteristics of Coronavirus Disease 2019 in China Dysregulation of immune response in patients with COVID-19 in Wuhan Clinical characteristics of refractory COVID-19 pneumonia in Wuhan Clinical and CT Imaging Features of the COVID-19 Pneumonia: Focus on Pregnant Women and Children The trafficking protein JFC1 regulates Rac1-GTP localization at the uropod controlling neutrophil chemotaxis and in vivo migration A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status Is COVID-19 receiving ADE from other coronaviruses New fronts emerge in the influenza cytokine storm Understanding the T cell immune response in SARS coronavirus infection Biochemical Aspects of Coronavirus Replication and Virus-Host Interaction Hospital stay, hour, mean (sd) This study was supported by the National Natural Science Foundation of China (Grants: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.